| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 10 |
| 1 | LORAZEPAM | 8 |
| 2 | DOXEPIN | 7 |
| 3 | DOXEPIN HYDROCHLORIDE | 7 |
| 4 | PANTOPRAZOLE | 7 |
| 5 | PANTOPRAZOLE SODIUM | 7 |
| 6 | PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | 7 |
| 7 | PANTOPRAZOLE SODIUM INJECTION | 7 |
| 8 | DROSPIRENONE AND ETHINYL ESTRADIOL | 5 |
| 9 | CETIRIZINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DROSPIRENONE AND ESTRADIOL | 2 | 0.0037 |
| 1 | DOXEPIN HYDROCHLORIDE | 7 | 0.0005 |
| 2 | NEOMYCIN OINTMENT | 1 | 0.0004 |
| 3 | BINIMETINIB | 1 | 0.0001 |
| 4 | OMALIZUMAB | 10 | 0.0001 |
| 5 | DROSPIRENONE AND ETHINYL ESTRADIOL | 5 | 0.0001 |
| 6 | PANTOPRAZOLE SODIUM INJECTION | 7 | 0.0001 |
| 7 | ENCORAFENIB | 1 | 0.0001 |
| 8 | CETIRIZINE HYDROCHLORIDE TABLETS | 3 | 0.0001 |
| 9 | BREXPIPRAZOLE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 10 |
| 1 | Benzodiazepine [EPC] | 8 |
| 2 | Estrogen [EPC] | 2 |
| 3 | Insulin Analog [EPC] | 2 |
| 4 | Progestin [EPC] | 2 |
| 5 | Arteriolar Vasodilator [EPC] | 1 |
| 6 | Atypical Antipsychotic [EPC] | 1 |
| 7 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 |
| 8 | General Anesthetic [EPC] | 1 |
| 9 | Interferon beta [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-IgE [EPC] | 10 | 0.0001 |
| 1 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 2 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 3 | General Anesthetic [EPC] | 1 | 0.0000 |
| 4 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 5 | Benzodiazepine [EPC] | 8 | 0.0000 |
| 6 | Estrogen [EPC] | 2 | 0.0000 |
| 7 | Progestin [EPC] | 2 | 0.0000 |
| 8 | Interferon beta [EPC] | 1 | 0.0000 |
| 9 | Insulin Analog [EPC] | 2 | 0.0000 |